The Deal Register
Database › M&A › Apotex Health Corp., with Cumberland Pharmaceuticals

M&A

Apotex Health Corp., with Cumberland Pharmaceuticals

Lane
M&A
Announced
01 Jul 2026
Province
Ontario
Industry
Healthcare & life sciences
Status
Announced
What the filing says
Apotex Health Corp. ("Apotex") (TSX: APTX ), the largest Canadian-based pharmaceutical company, today announced the closing of its previously announced strategic transaction with Cumberland Pharmaceuticals Inc. ("Cumberland"), a U.S. biopharmaceutical company, to integrate Cumberland's U.S. branded businesses into Apotex.
Releases (2)
  • 23 Apr 2026 — Apotex Announces Strategic Transaction with Cumberland Pharmaceuticals to Integrate their U.S. Branded Businesses
  • 01 Jul 2026 — Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals
Source

The terms are in the subscriber edition

This transaction carries 1 officer and advisor credit.

Subscribe

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe